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Background. Prenatal diagnosis of Optiz G/BBB syndrome (OS) is challenging because the characteristic clinical features, such
as facial and genitourinary anomalies, may be subtle at sonography and rather unspecific. Furthermore, molecular testing of the
disease gene is not routinely performed, unless a specific diagnosis is suggested. Method. Both familial and ultrasound data were
used to achieve the diagnosis of X-linked OS (XLOS), which was confirmed by molecular testing of MID1 gene (Xp22.3) at birth.
Results. Sequencing of MID1 gene disclosed the nucleotide change c.1285 +1 G>T, previously associated with XLOS. Conclusions.
This case illustrates current challenges of the prenatal diagnostic work-up of XLOS and exemplifies how clinical investigation,
including family history, and accurate US foetal investigations can lead to the correct diagnosis.
1. Introduction
The development of molecular cytogenetic techniques,
including array-based Comparative Genomic Hybridization
(aCGH), has offered a new platform in prenatal diagnosis,
in particular for evaluating fetuses with structural abnormal-
ities [1]. However, the prenatal diagnostic work-up should
always complement innovative cytogenetic and molecular
techniques with the traditional investigative tools, including
family history and accurate ultrasound (US) evaluation. This
point is illustrated by the present case report of a prenatally
diagnosed case of maternally inherited Optiz G/BBB syn-
drome.
2. Case Report
A 28-year-old nulliparous woman was referred at 19-week
gestation because of suspected cardiac defect. First-trimester
screening was unremarkable and nuchal translucency was
1.4mm. Foetal ultrasound showed a male foetus with a com-
plex congenital heart disease (CHD), including perimembra-
nous ventricular septal defect (VSD), ostium primum atrial
septal defect (ASD) or partial atrioventricular (AV) canal
defect (Figures 1(a) and 1(b)), and Persistent Left Superior
Vena Cava (PLSVC). CHD was associated with bilateral cleft
lip (Figure 2(a)), a slight hypertelorism, and bilateral pyelec-
tasis (Video) (in Supplementary Material available online at
http://dx.doi.org/10.1155/2015/830108).
Amniocentesis was performed at 20 weeks and both
karyotype and oligonucleotide array-based Comparative
Genomic Hybridization (aCGH) (44K Chip Agilent Tech-
nologies, Waldbronn, Germany) were reported as normal.
The parents were referred to genetic counselling, which
disclosed CHD (mild ASD and VSD spontaneously resolved)
associated with hypertelorism and hypospadias in a 1-year-
old maternal nephew. Based on family history, as well as
foetal US, a segregating X-linked disorder affecting the mid-
line structures was suspected. Following multidisciplinary
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(a) (b)
(c) (d)
Figure 1: Prenatal ultrasonographic foetal heart anomalies detected at 19 ((a) ostium primumASD; (b) perimembranous VSD) and 28 ((c)-(d)
agenesis of the venous duct) weeks of pregnancy.
(a) (b)
Figure 2: Bilateral cleft lip at 2D (a) and 3D (b) prenatal ultrasonographic scan at 19 and 28 weeks of pregnancy, respectively.
counselling, during which available options and risks were
discussed, the parents decided on pregnancy continuation.
US follow-up at 28-week gestation confirmed bilateral cleft lip
(Figure 2(b)), the slight hypertelorism, and bilateral pyelecta-
sis. Furthermore, increased cortical echogenicity of the right
kidneywith upper pole caliectasis, aswell as hypospadias, was
detected. Foetal echocardiography confirmed the complex
CHD. In addition, agenesis of venous duct, resulting in
an abnormal drainage of the umbilical vein into the foetal
venous circulation (Figures 1(c) and 1(d)), and a worsened
heart function with cardiomegaly were found. Thus, the
parents were thoroughly counseled about the potential risks
related to the discovery of the additional malformations and
the impaired heart function, including an early-preterm birth
or an intrauterine fetal death, as well as the need to schedule
delivery in a facility with neonatal and cardiac surgical
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(a) (b)
Figure 3: Phenotypical features of the affected newborn included a broad nasal bridge (a) and hypertelorism bilateral cleft lip and palate (b).
intensive-care unit. Antenatal corticosteroids for accelerating
fetal lung maturation were performed as well.
Preterm labour spontaneously occurred at 30 weeks.
Uncontrollable cyclic premature uterine contractions and a
dystocic labour required caesarean section.
A malformed male neonate, weighing 1254 g (34th cen-
tile), was delivered with Apgar score of 5 at 1 minute and
6 at 5 minutes. The main abnormalities occurred along the
body midline, including hypertelorism, cleft lip and palate,
and hypospadia (Figure 3). Crossed fused renal ectopia,
severe CHD, and imperforate anus were also present. Clinical
evaluation, together with family history, corroborated the
diagnosis of XLOS. Molecular testing ofMID1 gene (Xp22.2)
in the proband disclosed a nucleotide change c.1285 +1 G>T,
which is known to result in an abnormal exon 5 splicing [2].
The baby died 24 hours after birth of heart failure. The
parents denied consent to autopsy.
Subsequentmolecular testing in themother and her sister
showed that they were heterozygous for the same mutation,
in the absence of any obvious XLOS features. Genetic testing
was not available for the maternal nephew nor for the
maternal grandmother (Figure 4).
3. Discussion
Opitz G/BBB syndrome (OS; MIM number 145410 and MIM
number 300000), a congenital midline malformation syn-
drome, was first recognized in 1969 as two distinct disorders,
G syndrome and BBB syndrome [3, 4]. Later on these two
syndromes turned out to be a unique disease. Clinical mani-
festations of OS include midline defects with broad nasal
bridge, hypertelorism, prominent forehead, hoarseness, low-
set-posteriorly rotated ears, labiopalatine and laryngotra-
cheal abnormalities, dysphagia and gastroesophageal reflux,
central nervous system (CNS) abnormalities, causing major
motor skill defects, delayed development and intellectual
disability, genital anomalies, including hypospadias, cryp-
torchidism, and hypoplastic/bifid scrotum [5–8]. Other mal-
formations in less than 50% of cases include CHD, in
particular atrial and ventricular septal defects, patent ductus
arteriosus, coarctation of the aorta, imperforate or ectopic
Grandmother
(carrier?)
Aunt
(carrier)
Mother
(carrier)
Proband
(severely affected)
Male cousin
(mildly affected)
Figure 4: Pedigree of family in present study. Squares and circles
represent males and females, respectively. Blackened symbols indi-
cate individuals with X-linked Opitz syndrome confirmed byMID1
mutation analysis. Gray-coloured symbols indicate individuals with
a suspected mild form of X-linked Opitz syndrome, not confirmed
by MID1 mutation analysis. Small black dots within the circle
indicate carrier state confirmed by MID1 mutation analysis. Small
gray dots within the circle indicate carrier state not confirmed by
MID1mutation analysis.
anus, Dandy-Walker malformation, agenesis or hypoplasia of
the corpus callosum, and/or cerebellar vermis [9].
OS is genetically heterogeneous with an X-linked form,
(XLOS; Opitz G/BBB syndrome, type I) (OMIM 300552),
and an autosomal dominant form (ADOS; Opitz G/BBB syn-
drome, type II) (MIM 145410) [10].The disease gene of XLOS,
MID1, maps to chromosome Xp22.3 [11]. Approximately 40
mutations have been reported along the entire length of the
MID1 gene in both sporadic and familial cases [5, 6, 8, 10–15].
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Table 1: List of reported cases of prenatally detected maternally inherited Opitz syndrome (modified from Cheng et al., 2014 [1]).
Prenatal ultrasonographic
features
Type of prenatal
diagnosis
Delivery gestational age
and birth weight
Additional postnatal
phenotypical findings
Patton et al., 1986 [17] (i) Hydrops(ii) Polyhydramnios Ultrasonography
37 weeks
3012 g
(i) Posteriorly rotated ears
(ii) Loose skin folds in neck
(iii) Inguinal hernia
(iv) Anteriorly placed anus
Hogdall et al., 1989
[16]
(i) Hypertelorism
(ii) Enlarged cisterna
magna
Ultrasonography TOPII trimester
(i) Posteriorly rotated low-set
ears
(ii) Imperforate anus
Cho et al., 2006 [19] NA Cytogenetic analysis TOPI trimester NA
Tajima et al., 2010 [18] (i) Polyhydramnios(ii) Cleft lip Ultrasonography
35 weeks
2076 g
(i) Hypertelorism
(ii) Cleft palate
(iii) Hypospadias
(iv) Dysphagia
Cheng et al., 2014 [1] (i) Congenital heartdisease
Ultrasonography +
cytogenetic analysis
TOP
II trimester
(i) Absence of the corpus
callosum
TOP: termination of pregnancy.
NA: not available.
XLOS affects 1 in 50,000 to 100,000 males. Heterozygous
females can manifest mild features of OS, in particular
hypertelorism, while clinical presentation in affected males
is quite variable with some obligatory signs as hypertelorism,
laryngotracheal abnormalities, and hypospadias [5].
The first US prenatally diagnosed XLOS was reported
in 1989. The maternal family history included male deaths
associated with midline abnormalities. Fetal morphology
scan at 20 weeks disclosed a male foetus presenting with
hypertelorism, hypospadias, and enlarged cisterna magna.
The diagnosis was confirmed by pathologic examination after
pregnancy termination [16]. Two additional male prenatal
cases complicated by polyhydramnios, hydrops, andmultiple
midline malformations were diagnosed as affected by XLOS
after delivery [17, 18] (Table 1).
The first prenatal genetic diagnosis of XLOS concerned a
Korean who had previously delivered a son diagnosed with
XLOS at 4 years of age. He presented with hypertelorism, a
broad nasal bridge, a laryngeal cleft, and hypospadias. Her
two subsequent pregnanciesweremonitored by chorionic vil-
lous sampling and amniocentesis, respectively, and disclosed
in both cases a c.1798insC mutation in exon 13 of midline
protein1 (MID1) gene [19]. An additional prenatal case of
XLOS was diagnosed by aCGH in a foetus with CHD, which
turned out to be hemizygous for a 48Kb deletion of Xp22.2,
spanning the 3󸀠UTR region of the (MID1) gene [1] (Table 1).
The present case illustrates the current challenges of
prenatal diagnostic work-up of XLOS and raises a number of
issues.
First, carrier mothers either display an unremarkable
phenotype or, at most, manifest isolated hypertelorism, ham-
pering the possibility to identify, on a clinical basis alone,
females at risk, unless in the presence of one or more affected
males. In our family, both the mother and the maternal sister
were clinically normal and family history was negative for
male deaths associated with hypertelorism, hypospadias, and
cleft lip/palate [19]. An additional challenging aspect in our
family was that the male maternal nephew displayed only
mild features of XLOS. Accordingly, at routine anamnestic
interview these characteristics could be underestimated, as in
the present case, in which only after a long-lasting detailed
interview the mother admitted that her male nephew had
some minor congenital anomalies. This latter finding (male
maternal nephew affected), together with the fact that mid-
line defects can be transmitted in an X-linked manner,
allowed us the suspicion of a midline-X-linked disorder.
Second, the distinguishing features of XLOS, as hyper-
telorism and hypospadias, are rather subtle and quite often
are not detected by prenatal US.The wide spectrum of possi-
ble associated defects makes the clinical diagnosis quite dif-
ficult. In our case, the main clinical features, found at second
trimester US, were bilateral cleft lip and CHD, which occur
in less than 50% of XLOS patients [8]. However, accurate
US scans disclosed also some subtle diagnostic abnormalities,
that is, a slight hypertelorism, which were used as handles to
suggest the correct diagnosis.
In conclusion, we experienced a difficult prenatal diag-
nostic work-up of XLOS, which was successfully accom-
plished based on integration of family history, US findings,
and molecular test.
As a proper prenatal diagnosis of causative foetal disease
is desirable for suitable prenatal as well as neonatal care, it is
worth clinically accumulating evidence considering the inte-
gration of data coming from anamnesis and ultrasonographic
findings, in order to obtain final diagnosis by specific molec-
ular analysis. Such findings enable proper genetic counselling
and allowparents tomake appropriate decisions in their preg-
nancy. It also carries important implications to the family and
future pregnancies.
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